A new small-molecule drug produced a rapid antidepressant response similar to that of ketamine when tested in mice, a new Yale-led study published April 16 in The Journal of Clinical Investigation shows.
The effects of the drug, called NV-5138, in rodent models mimicked the rapid actions of the anesthetic ketamine, a variation of which, Esketamine, was recently approved by the FDA for use in depressed patients who do not respond to other medications. However, there still remain lingering safety concerns over use of ketamine, as well as Esketamine, both of which have the potential to induce psychosis-like states and also have a potential for abuse.
“Recent research has raised the possibility that a new drug, such as NV-5138, could be developed that is rapid-acting but also more efficacious and safer than current formulations of ketamine,” said senior author Ron Duman, the Elizabeth Mears and House Jameson Professor of Psychiatry and professor of neuroscience.
The experimental drug does not directly stimulate neuronal activity like ketamine, but like ketamine, it spurs the growth of synapses or connections between neurons, the loss of which is associated with chronic stress and depression. The research team also showed that synaptic connectivity markers were rapidly restored in a mouse model of anhedonia, a core symptom of depression marked by an inability to experience pleasure. Mice administered a single dose of the drug also showed marked improvements in other depression-related behaviors.
The drug is being developed by Navitor Pharmaceuticals Inc., which funded the study. It is currently undergoing Phase I testing in human patients.
The Latest on: Depression
via Google News
The Latest on: Depression
Guys Are Sharing How They've Helped Friends Deal With Depression
on June 15, 2019 at 9:27 am
Mental health remains a subject surrounded by stigma, which is slowly being broken down through open and honest conversations. Communication on this topic is especially crucial for men, who often ... […]
New study suggests abortion drugs linked to depression, anxiety in mothers
on June 14, 2019 at 6:19 pm
June 14, 2019 (LifeSiteNews) — After more than three years of research, a team of behavioral neuroscientists at Franciscan University of Steubenville has released the findings of a study that suggests ... […]
Father Shares His Battle with Postpartum Depression After Birth of First Son
on June 14, 2019 at 4:33 pm
A Kansas City father is speaking out about his battle with postpartum depression following the birth of his first son. ... […]
Depression Called a 'Core Symptom' of MS
on June 14, 2019 at 1:35 pm
SEATTLE — Because brain imaging studies increasingly show that depression experienced by patients with multiple sclerosis (MS) may be linked as much to brain changes caused by the disease itself as to ... […]
News photo editor Guy Reynolds battled cancer, depression but never lost 'the eye of an artist'
on June 14, 2019 at 11:40 am
When Guy Reynolds was at his best, he was a creative force — a gifted photographer with a quirky eye. As a Dallas Morning News photo editor and as a visual artist, he captured the odd beauty in the ... […]
Postpartum Depression Strikes Men, Too - It Happened to Me
on June 14, 2019 at 8:04 am
When my first child, our son Zachary, was born in 2013, I was as in the dark about postpartum depression in men as anyone else. As a pediatrician, I had been trained to look for signs of postpartum ... […]
Depression symptoms greater in mothers with prior eating disorders
on June 14, 2019 at 7:15 am
(HealthDay)—Women with eating disorders experience persistently greater depressive symptoms across the life-course, according to a study recently published in the British Journal of Psychiatry. ... […]
How Ketamine Opens a New Era for Depression Treatment
on June 13, 2019 at 9:00 pm
Researchers have discovered that ketamine, a drug of choice for club-goers for decades, can be used to fight severe cases of the blues. For more than three decades, patients seeking treatment for ... […]
Genes and Depression
on June 13, 2019 at 8:58 pm
Depression is a common mental health condition. The World Health Organization (WHO) says depression affects about 300 million people worldwide. It’s the most common illness and the leading cause of ... […]
Cannabis for Depression?
on June 13, 2019 at 5:20 pm
Over 16 million Americans suffer from major depressive disorder, and it is the leading cause of disability in the U.S. for those aged 15 to 44. Treatment can be complicated: not all individuals ... […]
via Bing News